Follow
Aarti Sevilimedu
Aarti Sevilimedu
Dr.Reddy's Institute of Life Sciences, Hyderabad, India
Verified email at drils.org
Title
Cited by
Cited by
Year
RNA aptamers directed to discrete functional sites on a single protein structural domain
H Shi, X Fan, A Sevilimedu, JT Lis
Proceedings of the National Academy of Sciences 104 (10), 3742-3746, 2007
772007
Larval zebrafish model for studying the effects of valproic acid on neurodevelopment: An approach towards modeling autism
S Dwivedi, R Medishetti, R Rani, A Sevilimedu, P Kulkarni, P Yogeeswari
Journal of pharmacological and toxicological methods 95, 56-65, 2019
542019
An RNA aptamer that interferes with the DNA binding of the HSF transcription activator
X Zhao, H Shi, A Sevilimedu, N Liachko, HCM Nelson, JT Lis
Nucleic acids research 34 (13), 3755-3761, 2006
542006
TFIIB aptamers inhibit transcription by perturbing PIC formation at distinct stages
A Sevilimedu, H Shi, JT Lis
Nucleic acids research 36 (9), 3118-3127, 2008
302008
A DNAzyme based knockdown model for Fragile-X syndrome in zebrafish reveals a critical window for therapeutic intervention
R Medishetti, R Rani, S Kavati, A Mahilkar, V Akella, U Saxena, P Kulkarni, ...
Journal of Pharmacological and Toxicological Methods 101, 106656, 2020
102020
Magnetic nanoparticle formulation for targeted delivery of chemotherapeutic irinotecan to lungs
P Kulkarni, M Rajadurai, A Sevilimedu, S Basaveni, S Yellanki, ...
Drug Delivery and Translational Research 8, 1450-1459, 2018
72018
The known unknowns: Missing pieces in in vivo models of Fragile X syndrome
P Kulkarni, A Sevilimedu
Journal of Rare Diseases Research and Treatment 5 (1), 1-9, 2020
62020
Drug REputposing using AI/ML tools - for Rare Diseases ( DREAM-RD) : A case study with Fragile X Syndrome ( FXS)
K Agastheeswaramoorthy, A Sevilimedu
biorxiv, 2020
42020
CRISPR-Cas9-induced gene knockout in zebrafish
R Medishetti, K Balamurugan, K Yadavalli, R Rani, A Sevilimedu, ...
STAR protocols 3 (4), 101779, 2022
32022
Embryonic Zebrafish models using DNAzyme mediated knockdown
A Sevilimedu, P Kulkarni
US Patent App. 16/978,537, 2021
32021
Double PEGylation Significantly Improves Pharmacokinetic Properties of Irinotecan Containing Nanoparticles in a Zebrafish Model
U Saxena, M Rajadurai, S Basaveni, S Yellanki, R Medishetti, ...
Current Nanomedicine (Formerly: Recent Patents on Nanomedicine) 9 (2), 173-181, 2019
22019
An RNA aptamer to HP1/Swi6 facilitates heterochromatin formation at an ectopic locus in S.pombe
R Rani, AM Yaseen, A Malwade, A Sevilimedu
RNA biology 16 (6), 742-753, 2019
12019
Antibacterial Nanoparticles Based on Fluorescent 3‐Substituted Uridine Analogue
ER Reddy, AM Yaseen, A Rizvi, GS Deora, S Banerjee, A Sevilimedu, ...
ChemistrySelect 2 (1), 557-561, 2017
12017
Impaired ovarian development in a zebrafish fmr1 knockout model
R Rani, NS Sri, R Medishetti, K Chatti, A Sevilimedu
bioRxiv, 2024.02. 10.579749, 2024
2024
An efficient and cost-effective method for directed mutagenesis at multiple dispersed sites—a case study with Omicron Spike DNA
R Rani, KVL Parsa, K Chatti, A Sevilimedu
Biology Methods and Protocols 8 (1), bpac037, 2023
2023
Corrigendum to: Double PEGylation Significantly Improves Pharmacoki-netic Properties of Irinotecan Containing Nanoparticles in a Zebrafish Model
U Saxena, M Rajadurai, S Basaveni, S Yellanki, R Medishetti, ...
Current Nanomedicine (Formerly: Recent Patents on Nanomedicine) 11 (2), 139-139, 2021
2021
Signals that Distinguish Noncoding RNA Scaffolds from mRNAs
D Moazed, N Iglesias, A Sevilimedu, R Yu, G Jih, R Kruger, S Gygi
The FASEB Journal 29, 361.2, 2015
2015
Using RNA Aptamers that Bind TFIIB and TBP to Probe Preinitiation Complex Assembly in Vitro and in Vivo
AS Veeravalli
Cornell University, 2008
2008
The system can't perform the operation now. Try again later.
Articles 1–18